Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / ADAR1 Capital Management, LLC
Form 13F · Q2 2026

ADAR1 Capital Management, LLC

CIK 1940272申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$21.9亿
申報組合市值
277
持倉數量
11
Quarters on record
Top 50
持倉數量

ADAR1 Capital Management, LLC——持倉

共 277 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1ABVX Abivax Sa1.8M+29.5%$2.4亿11.0%
2PTGX Protagonist Therapeutics Inc960,863−3.3%$1.2亿5.4%
3ROIV Roivant Sciences Ltd3.2M−3.9%$1.1亿5.1%
4SPY State Str Spdr S&P 500 Etf T129,087+70.0%$9640万4.4%
5IMVT Immunovant Inc2.3M−13.0%$8980万4.1%
6ZLAB Zai Lab Ltd3.4M+136.4%$6401万2.9%
7AGIO Agios Pharmaceuticals Inc1.3M+815.6%$4780万2.2%
8CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In1.2M+7.3%$4573万2.1%
9EA SERIES TRUST Ea Series Trust337,125+0.0%$3947万1.8%
10CYTK Cytokinetics Inc457,907−27.6%$3901万1.8%
11SEPN Septerna Inc940,747−13.7%$3151万1.4%
12AVR Anteris Technologies Global3.1M−17.0%$3098万1.4%
13EDIT Editas Medicine Inc8.9M—$2880万1.3%
14DNLI Denali Therapeutics Inc1.0M−45.0%$2647万1.2%
15SYRE Spyre Therapeutics Inc283,982−16.1%$2521万1.2%
16VIR Vir Biotechnology Inc2.5M−10.5%$2503万1.1%
17PRAX Praxis Precision Medicines I74,253+4850.2%$2486万1.1%
18INSM Insmed Inc228,520+545.7%$2436万1.1%
19CLDX Celldex Therapeutics Inc New619,542+44.8%$2305万1.1%
20VKTX Viking Therapeutics Inc574,038+152.1%$2239万1.0%
21TSHA Taysha Gene Therapies Inc3.0M+2.0%$2071万0.9%
22MNPR Monopar Therapeutics Inc217,595−17.7%$2015万0.9%
23OVID Ovid Therapeutics Inc7.4M+63.2%$1995万0.9%
24ELVN Enliven Therapeutics Inc387,718+17.7%$1968万0.9%
25ENTA Enanta Pharmaceuticals Inc1.3M+2518.0%$1960万0.9%
26NKTR Nektar Therapeutics244,184+51.4%$1705万0.8%
27INSP Inspire Med Sys Inc374,617−7.5%$1671万0.8%
28RVMD Revolution Medicines Inc87,509−34.6%$1639万0.7%
29ESTA Establishment Labs Hldgs Inc185,619−13.0%$1593万0.7%
30PRTA Prothena Corp Plc1.6M−1.7%$1522万0.7%
31RYTM Rhythm Pharmaceuticals Inc136,158−35.6%$1512万0.7%
32IKT Inhibikase Therapeutics Inc7.4M+11.8%$1500万0.7%
33QURE Uniqure Nv324,672+326.0%$1495万0.7%
34RLYB Rallybio Corp926,352+4411.1%$1482万0.7%
35REGN Regeneron Pharmaceuticals22,208+82.7%$1385万0.6%
36IVA Inventiva Sa3.6M+65.9%$1363万0.6%
37STRO Sutro Biopharma Inc404,014−23.0%$1341万0.6%
38IONS Ionis Pharmaceuticals Inc166,286+3.7%$1318万0.6%
39BBIO Bridgebio Pharma Inc176,689+87.4%$1316万0.6%
40SRPT Sarepta Therapeutics Inc730,649+178.8%$1313万0.6%
41CTMX Cytomx Therapeutics Inc.3.4M−1.3%$1262万0.6%
42VOR Vor Biopharma Inc680,626—$1253万0.6%
43SPDR SERIES TRUST Spdr Series Trust135,585+0.0%$1243万0.6%
44EQ Equillium Inc3.8M+0.9%$1203万0.6%
45ANL Adlai Nortye Ltd1.0M+763.2%$1170万0.5%
46CLYM Climb Bio Inc822,649+37.6%$1073万0.5%
47HLXC Helix Acquisition Corp Iii1.0M+0.0%$1060万0.5%
48ZURA Zura Bio Ltd1.8M+179.1%$1038万0.5%
49OKUR Onkure Therapeutics Inc2.2M−8.1%$1021万0.5%
50MAZE Maze Therapeutics Inc339,276+577.3%$1012万0.5%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。